Biobanks facilitate large-scale tests of hypotheses that may advance health, but whether biobanking participants adequately comprehend the potential uses of their data should concern researchers and the public.
Aside from areas related to medical imaging, the implementation of AI in health care is still in early stages. Notwithstanding concerns about potential risks, evaluation of current evidence found benefits associated with use of some AI applications.
This report provides an independent assessment of the breadth, scope, and impact of health services and primary care research funded by the U.S. Department of Health and Human Services and U.S. Department of Veterans Affairs from FYs 2012 to 2018.
Pulling the UK COVID-19 vaccination program together was an immense logistical and technical effort. Had it not been for the working practices mandated by the lockdown, it would have been even more difficult. What changed over the pandemic to allow this to happen?
To advance understanding of primary care clinic productivity, the authors reviewed relevant literature and convened stakeholders to explore definitions, identify relevant tools, and establish consensus on key aspects of primary care productivity.
Inventions help people around the world live longer, healthier, and more-productive lives. The inventions of Lemelson-MIT Prize winners illustrate the scientific, technological, economic, and social effects that inventions can have on society.
RAND mathematician Mary Lee examines technologies that make up the Internet of Bodies (IoB); explores their benefits, risks, and ethical implications; surveys the regulatory landscape; and makes recommendations to balance IoB risks and rewards.
The rise of devices that connect the human body to the web is accelerating rapidly. This Internet of Bodies could revolutionize health care and improve our quality of life. But without appropriate guardrails, it could also jeopardize our most intimate personal information and introduce several ethical concerns.
In this video conversation, Jennifer Bouey discusses RAND's rapid COVID-19 response, including insights and analysis to help strengthen and safeguard communities, rethink and retool institutions, and determine the best ways forward.
RAND Europe's Sonja Marjanovic explains how changes in society have brought about opportunities for the pharmaceutical industry to innovate to better meet the needs of patients and health care systems.
Brain-computer interfaces give humans the ability to directly control machines with their minds. Before this emerging technology matures, it's important for developers to weigh the opportunities against the risks.
Health services research and primary care research portfolios funded by agencies have distinct focus areas, and most overlap is complementary, but there are gaps in research, driven by the complexity and pace of change in the U.S. health system.
Experts consider how monitoring the development of a COVID-19 vaccine could help to identify which of the approaches speeding development and deployment could be usefully applied more widely in the future.
Biological outbreaks have been a fear among experts for decades and human activities present windows of vulnerability. To address this, America needs to have a new approach to biosafety and biosecurity that addresses the full range of biological threats that humankind and the global environment will face in the future.